R&D
NEWGLAB R&D
One of the missions of NewG Lab Pharma
(NGLP) will be to develop novel anticancer
therapeutics that extend the life of cancer patients
without compromising the quality of life.
- R&D
- Clinical Development
One of the missions of NewG Lab Pharma
(NGLP) will be to develop novel anticancer
therapeutics that extend the life of cancer patients
without compromising the quality of life.
| Pipeline | Indication | IP STATUS | Location | Status |
|---|---|---|---|---|
| KAT-001 | Liver Cancer | License-In | US | Prepare Clinical Trials |
| KAT-002 | Bladder Cancer | License-In | US | Prepare Clinical Trials |
| KAT-003 | Melanoma | License-In | US, AUS | Prepare Clinical Trials |
| KAT-004 | Breast Cancer | License-In | US | Prepare Clinical Trials |
| KAT-005 | Pancreatic Cancer | Additional Study | US | Prepare Clinical Trials |
| KAT-006 | Leukemia | Additional Study | US | Prepare Clinical Trials |
| KAT-007 | Prostate Cancer | - | TBD | - |
| KAT-008 | Lung Cancer | - | TBD | - |
| KAT-009 | Glioblastoma | - | TBD | - |
| KAT-010 | Colorectal Cancer | - | TBD | - |
Business Plan developing based
on the treatment of Kozmo